Rostislav Beyder, PA
Physician Assistant · Charlotte, NCNPI 1528341864
Payments from drug & device makers
Across 166 payments — averaging $20.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$548
- Novo Nordisk$457
- AstraZeneca$372
- Astellas Pharma US Inc$310
- Pfizer$278
- Lilly USA, LLC$220
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,37098%
- Education$832%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $548 |
| Novo Nordisk | 30 | $457 |
| AstraZeneca | 18 | $372 |
| Astellas Pharma US Inc | 13 | $310 |
| Pfizer | 15 | $278 |
| Lilly USA, LLC | 6 | $220 |
| Viiv Healthcare Company | 6 | $128 |
| Amgen | 7 | $120 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $111 |
| Bayer | 2 | $111 |
| Boehringer Ingelheim | 5 | $98 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $85 |
| Idorsia Pharmaceuticals US Inc | 4 | $78 |
| GSK | 4 | $69 |
| Abbott | 3 | $68 |
| Exact Sciences | 3 | $52 |
| Novartis | 2 | $49 |
| Merck | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $40 |
| Indivior Inc. | 1 | $40 |
| Insightec,inc | 1 | $33 |
| Gilead | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $21 |
| Edwards Lifesciences | 1 | $19 |
| Tolmar, Inc. | 1 | $17 |
| Mylan Specialty L.p. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOUNJARO$109
How this compares
$3,452 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 57 | $89,478 |
| RybelsusSemaglutide | 11 | $16,414 |
| EliquisApixaban | 17 | $16,240 |
| FarxigaDapagliflozin Propanediol | 17 | $14,728 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $11,075 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 39 | $8,027 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 93 | $7,193 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $5,810 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 45 | $5,000 |
| Novolog FlexpenInsulin Aspart | 17 | $2,880 |
| Icosapent Ethyl | 11 | $2,302 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 80 | $1,921 |
| Gabapentin | 76 | $1,688 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 16 | $1,079 |
| Atorvastatin Calcium | 204 | $1,039 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $457 | $105,89268 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $372 | $31,61348 claims |
| PfizerEliquis | $278 | $16,24017 claims |
| Indivior Inc.Suboxone | $40 | $8,02739 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Charlotte
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Kristin CabedaCharlotte$135K
- Meghan EmigCharlotte$124K
- Juleidy TurnipseedCharlotte$84K
- Erin SiceloffCharlotte$50K
- Ronald RodriguezCharlotte$31K
- Lamiaa TolbaCharlotte$29K
- Sanaya GandhiCharlotte$29K
- Jacqueline LeyrerCharlotte$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.